Outsourcing For Beginners: Cell & Gene Therapy Modalities

Cell and gene therapy (CGT) holds immense potential to treat and even cure previously untreatable diseases, but the development and manufacturing challenges can be overwhelming, especially for companies entering this field for the first time.

This eBook is designed to demystify the world of CGT outsourcing, providing valuable insights to help you make informed, strategic decisions. We will delve into the rapidly evolving field of allogeneic cell therapies, exploring the opportunities and obstacles they present, and how strategic outsourcing can help accelerate their development. The eBook will cover the tools, technologies, and emerging trends shaping the future of cell therapy manufacturing, with a particular focus on the pivotal role of viral vectors. You’ll learn about plug-and-play platforms that streamline viral vector production, as well as a case study highlighting the successful scale-up of lentiviral vectors.

Additionally, we’ll cover strategies for high-yield plasmid production and optimizing upstream processes, along with a look at the path towards standardized viral vector manufacturing, focusing on efficiency, quality, and scalability. Whether you're an experienced biopharmaceutical professional or a newcomer to the CGT space, this eBook will equip you with the knowledge and strategies necessary to navigate the complexities of outsourcing and drive your CGT projects toward successful outcomes.